For a hospital billing department, a denied insurance claim is more than a line item. It is a starting gun for a race against a clock, a manual process of poring over clinical notes, coding guidelines, and payer policies to craft a compliant appeal. The scale of the problem is staggering, with an estimated $260 billion in inpatient claims denied to American hospital systems annually [PMC]. Aegis, a seed-stage startup from Y Combinator's Spring 2025 batch, is betting that this race can be run by an AI.
The company's platform is designed to automate the end-to-end appeals workflow. It integrates with electronic health records and payer portals to detect denials, generate and submit compliant appeal letters, and track outcomes [Y Combinator, Spring 2025].
The Wedge in a $300 Billion Bottleneck
The market Aegis is entering is a well-documented, grinding bottleneck in healthcare economics, often cited as a $300 billion problem tied to billing complexity [Forbes, Aug 2025]. The startup's wedge is specificity. Rather than building another broad revenue cycle management suite, it focuses narrowly on the appeals process after a denial has occurred. The early traction signal is a reported $440,000 in revenue generated by a four-person team in 2025 [GetLatka].
A Technical Team Learning Healthcare
The founding trio of Krishang Todi, Aarav Bajaj, and Dhanya Shah are close friends from Carnegie Mellon University, bringing complementary technical skills but no prior deep healthcare operating experience.
| Founder | Role | Background |
|---|---|---|
| Krishang Todi | CEO | Economics/Mathematics; fixed-income risk modeling at an Indian fund [Y Combinator, Spring 2025]. |
| Aarav Bajaj | Co-Founder | Computer Science/ML; former Palantir engineer and AI researcher at CMU [Y Combinator, Spring 2025]. |
| Dhanya Shah | COO | Information Systems/CS; seasoned full-stack engineer [Y Combinator, Spring 2025]. |
The Regulatory and Competitive Gauntlet
The path forward is fraught with challenges that go beyond typical software sales. Aegis operates in a heavily regulated environment where an incorrectly generated appeal could have compliance implications. The platform's ability to integrate deeply and securely with legacy EHR systems like Epic and Cerner will be a major technical hurdle and a key buying criterion. Furthermore, while no direct competitors are named in the sources, the startup is entering a space crowded with established revenue cycle management giants and a growing number of AI-enabled coding and billing assistants.
The company's early metrics and YC backing provide a launchpad, but the next twelve months will be critical. The key signals to watch will be the signing of a first named hospital system customer, the publication of any third-party validation of its appeal win rates, and the expansion of the team with healthcare revenue cycle leadership.